PROF — Profound Medical Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1628808 ·
Last close
$6.62
Market Cap
$240.74M
52W High
$7.89
52W Low
$5.02
ADV30
67,223
Next earnings
2026-05-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 5,337,000 | 3,832,000 | -8,021,000 | -7,053,000 | 73,456,000 | 50,295,000 | 14,032,000 |
| Dec 2025 | 5,977,000 | 3,991,000 | -7,369,000 | -8,175,000 | 77,475,000 | 59,723,000 | 11,041,000 |
| Sep 2025 | 5,289,000 | 3,931,000 | -8,913,000 | -7,977,000 | 42,305,000 | 24,826,000 | 10,162,000 |
| Jun 2025 | 2,211,000 | 1,618,000 | -13,806,000 | -15,695,000 | 49,668,000 | 35,195,000 | 10,409,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-38,207,000
Investing CF
—
Financing CF
$41,138,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.41
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-287,740,000
Inventory
$8,238,000
Receivables
$7,200,000
ST Investments
—
EBIT TTM
$-41,254,000
Pretax Income TTM
$-42,319,000
Interest Exp TTM
$199,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$18,814,000
EBITDA
$-37,612,000
Free Cash Flow
$-22,768,124
Enterprise Value
$197,904,848
Total Cash
$50,295,000
Total Debt
$7,463,000
Shares Out
36,337,637
Trailing EPS
$-1.24
Book Value
$1.64
ROE
-70.6%
ROA
-35.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,098,000 | -41,254,000 | -42,570,000 | 77,475,000 | 11,041,000 | — | -38,207,000 |
| Dec 2024 | 10,680,000 | -33,062,000 | -27,816,000 | 70,234,000 | 9,812,000 | — | -23,453,000 |
| Dec 2023 | 7,199,000 | -28,651,000 | -28,323,000 | 43,956,000 | 12,732,000 | — | -22,609,000 |
| Dec 2022 | 6,681,000 | -29,602,000 | -28,669,000 | 64,421,000 | 12,417,000 | — | -25,800,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.75
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $6.71 · call volume: 32 · put volume: 200Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | $245.51M | $4.10 | — |
| TLSI | TriSalus Life Sciences, Inc. | $231.54M | $3.77 | — |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $263.38M | $4.06 | — |
| UTMD | UTAH MEDICAL PRODUCTS INC | $216.00M | $67.84 | — |
| SGHT | Sight Sciences, Inc. | $279.12M | $5.13 | — |
News headlines (Yahoo Finance, 1h cache)
Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?
2026-05-18 13:55 · Yahoo
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
2026-05-15 10:30 · Yahoo
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
2026-05-14 11:00 · Yahoo
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
2026-05-14 00:41 · Yahoo
Profound Medical Q1 Earnings Call Highlights
2026-05-08 21:07 · Yahoo
Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates
2026-05-07 21:55 · Yahoo
Profound Medical Down 8.5% After Hours as Its Q1 Loss Narrows, Revenue More Than Doubles, Beats Estimates
2026-05-07 20:41 · Yahoo
Profound Medical Reports Strong First Quarter 2026 Financial Results
2026-05-07 20:05 · Yahoo
Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near Future
2026-05-03 12:04 · Yahoo
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates
2026-04-30 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.